Page 161 - Syndipharma

Tehran Darou Pharmaceutical Co.

IRANIAN PHARMACEUTICAL COMPANIES DIRECTORY

Tehran Darou Pharmaceutical Company is one of the highly fast growing pharmaceutical companies with several
production lines. It was established in 1955 by the name of Myecin Laboratory and the name of Tehran Darou was
given to the company in 1984 that runs totally by private sector. On March 1999, Tehran Darou was listed on Tehran
Stock Exchange.
The company is located in Tehran outskirt, but the corporate headquarter is just in Tehran. The Tehran Darou is
approximately 9 Km far from the capital. It is accessible via different routes like subway, local buses and Taxi. The
distance from IKI Airport would be around 30 Km. Site Address is:
Tehran Darou Pharmaceutical Co.9th Km, Karaj Makhsous Road Tehran, Iran.
Phone: +98-21 48032 000 / +98-21 4450 4841-3
Fax: +98-21 4450 4840
Web site : www.tehrandarou.com
E-mail: info@tehrandarou.com
Dr. Masoud Abdoulkarimi , a very well known and experienced pharmacist in pharmaceutical industries, is Managing
Director of the company. Senior and experienced personnel are always available by providing extensive support in
the areas of new technologies, Novel Drug Delivery Systems, R&D, QC and QA. Tehran Darou recruited very highly
qualified, educated and motivated staff, with of course having good experiences in the field of Industrial pharmaceu-
ticals. The total number of employees is 285.

Company Profile:
Tehran Darou manufactures and markets very wide range of pharmaceutical products under cGMP rules and regu-
lations and other internationally accepted standards. Tehran Darou Co. quality management system operates within
the requirements of local and international pharmaceutical guidelines and regulatory authorities and Pharmacope-
ias. In Tehran Darou Co. the Quality Management System has been established in compliance with ICH Q10 phar-
maceutical quality system .ICH Q10 that is based on International Standards Organization (ISO) quality concepts,
includes applicable Good Manufacturing Practice (GMP) regulations described in ICH Q7 and complements ICH Q8
“Pharmaceutical Development” , ICH Q9“Quality Risk Management”. & PIC/s Guidelines. This system encompasses
the organizational structure, procedures, processes and resources, as well as activities to ensure confidence that the
all products will meet their intended specifications.
The Quality Management System of Tehran Darou Co.has been established based on ISO 9001: 2015 , cGMP,ICH Q10
& PIC/s Pharmaceutical Quality System principles, enables development of high quality, safe and effective products
according to local and global standards and regulations. Tehran Darou Co. Quality Management System implements
and maintains a state of control through development and usage of effective monitoring and control systems for
process performance and product quality. The system provides assurance of ongoing suitability and capability of
processes and facilitates continuous improvement. In addition, to protect business and maintain quality of products,
a systematic process has been developed for identification, assessment and management of potential and existing
risks.
Tehran Darou Co. contain different departments include Regulatory, QA, R&D, Production, QC, Technical, Financial,
Commercial and sale & Marketing which all of them are active.
The company quality policy states: Improving the health standard of the society is our first aim.
In Tehran Darou Pharmaceutical Company, marketing and sales departments have distinct role in market processing,
advertisements, public displays, customer support and getting in touch with physicians, pharmacies and other target
groups.

160